Navigation Links
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
Date:6/17/2008

he most common adverse events reported are skin irritation where gel is applied, breast development or tenderness, acne, prostate enlargement, changes in lab test results, and changes in urinary habits.

Remember, this information does not take the place of the advice you get from your doctor or other health care professional. Always talk with your doctor if you have questions about AndroGel.

Unimed Pharmaceuticals, LLC., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., holds the exclusive rights to AndroGel in the United States.

About Solvay Pharmaceuticals, Inc.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit http://www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, and men's and women's health. Its 2007 sales were EUR 2.6 billion and it employs more than 9,000 people worldwide. For more information, visit http://www.solvaypharmaceuticals.com.

SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs more than 28,000 people in 50 countries. In 2007, its consolidated sales amounted to EUR 9.6 billion, generated by its three sectors of activity: Chemicals, Plastics and Pharmaceuticals. Solvay (NYSE Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the NYSE Euronext stock exchange in Brussels. Details are available at http://www.solvay.com.


'/>"/>
SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
6. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
7. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
8. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
9. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
10. Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients
11. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ERT (Nasdaq: ERES ), an...mpany,s President and CEO, and Keith Schneck, the ...heduled to present at the 21st Annual Piper Jaffra...r 1, 2009 in New York City, New York. ,, Intere...ng the Company,s corporate website at http://www....
(Date:11/25/2009)...v. 25 For many of the mi...he 27 million living with untreated hearing loss ...iologist Cindy Beyer. ,, Dr. Beyer, senior vice...a,s largest hearing care and hearing aids compan...ss, frustration, and social isolation, "which can ...
(Date:11/25/2009).... 25 /PRNewswire-Asia-FirstCall/ -- China Sky One,...pany") (Nasdaq: CSKI ), a,leading fully integrate...over-the-counter drugs in the People,s Republic of...ecently passed the Chinese National Institute for,...cts ("ICPBP") examination,for two of its new produ...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3MU researchers create drought conditions to unearth solutions 9444 1MU researchers create drought conditions to unearth solutions 9444 2Health Care Statement of Catholic Charities USA 53361 1AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries 53358 1AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries 53358 2AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries 53358 3AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries 53358 4AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries 53358 5
(Date:11/29/2009)...s urine production, experts say , , SUN...p during the night to urinate shouldn,t automatica...athing-related sleep disorder, could be the cause....n, or nocturia, is comparable to loud snoring as a... which soft tissue in the throat blocks the flow o...
(Date:11/28/2009)... change after 30-minute psychosocial intervention,...Day News) -- A program that gets persistent drunk ...gerous behavior may lead to significant and long-l...ew study included 184 men and women with two or mo...ndomly assigned to one of two interventions. The f...
(Date:11/27/2009)...ins Ltd. today issued its latest biochemical analy... the lethality of the virus has dropped from its p...utbreak in the spring of 2009 to resting non-epide...nfectivity count, however, remains increased. , ... 2009 -- Biotech firm Replikins Ltd., which has an...
(Date:11/27/2009)...RNewswire-FirstCall/ -- Shamir Optical Industry Lt...er of innovative products and technology to the op...rd of directors had declared a dividend distributi...ximately NIS 37.62 million based on the November 2...ximately US$ 0.609 (approximately NIS 2.3 based on...
(Date:11/27/2009)...; announced today that Spectrum Health (Grand Rapi...e orthopedic templating solution and its TraumaCad... (PRWEB) November 27, 2009 -- Voyant Health&tra...pids, Michigan) has licensed its TraumaCad Enterpr...ad Extend workflow solution, to allow its orthoped...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...T LAUDERDALE, Fla., April 3 eDiets.com, Inc. (N...at-home diet, fitness and healthy lifestyle soluti...m the NASDAQ Stock Market indicating that the mark...liance with NASDAQ Marketplace Rule 4310(c)(3)(B)....
...s of the toxin in leg bones are tied to poorer sco... (HealthDay News) -- Exposure to higher levels of ... taking a toll on the brains of older American wom... the metal) or bones (an indication of cumulative ...
...HESDA, Md., April 3 Technology Informatics Guidin...United States realize its 10-year goal of electron...ch started as a grass-roots initiative, now involv...ing students to fully engage in the unfolding digi...
...LADELPHIA, April 3 Hahnemann University Hospital,... Gold Seal of Approval(TM) for health care quality...pumps that allow damaged hearts to continue functi...itation for our VAD program because we wanted to d...
...RISBURG, Pa., April 3 To support the growing numb...g as a result of the recent increase in federal ci...nded smokers to call Pennsylvania,s toll-free Quit...ave support are more likely to succeed," said Secr...
...MINGTON, Del., April 3 AstraZeneca (NYSE: AZN )... Administration (FDA) posted to its web site -- an...he April 8, 2009 Psychopharmacologic Drugs Advisor...) for SEROQUEL XR(R) (quetiapine fumarate) Extende...
Other Medicine News:Health News:eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities 2Health News:eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities 3Health News:Accumulated Lead May Affect Older Women's Brains 2Health News:TIGER Moves into Phase III: Implementation 2Health News:TIGER Moves into Phase III: Implementation 3Health News:Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices 2Health News:Pennsylvania Department of Health Helps Smokers Trying to Quit in Wake of Federal Cigarette Tax Hike 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 3Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 4Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 5
The Elite™ Premium Shoulder Instrument Systems
Suture Cutter, straight
Suture Cutter, 15 Up Curve
Suture Scissor
Medicine Products: